| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +52% |
| 3Y CAGR | +16% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +111% |
| 3Y CAGR | +39% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,804.00 -10.00 (0.36%) | 21,386.27 | 31.54 | 6.35 | ||
PfizerPFIZER | ₹4,345.00 -251.50 (5.47%) | 21,017.65 | 28.59 | 5 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,899.00 +48.00 (0.70%) | 17,134.25 | 101.01 | 19.63 | ||
Marksans PharmaMARKSANS | ₹337.40 +2.35 (0.70%) | 15,187.78 | 29.14 | 5.02 |